Oncology
 |
|
8 october 2019 00:03:41 |
| CLEC5A expressed on myeloid cells as a M2 biomarker relates to immunosuppression and decreased survival in patients with glioma (Cancer Gene Therapy) |
|
Tweet |
| 225 viewsCategory: Oncology |
 Oncogenic HOXB8 is driven by MYC-regulated super-enhancer and potentiates colorectal cancer invasiveness via BACH1 (Oncogene)Tumour cells co-opt synaptic signalling (Nature Reviews Cancer) 
|
| blog comments powered by Disqus |
MyJournals.org
The latest issues of all your favorite science journals on one page
The latest issues of all your favorite science journals on one page
